Concepedia

Tanya Ramey

TR

Statistics

Publications

7

Citations

424

H-Index

7

Active since

2008

Affiliations

Pfizer (United States)(Current)

Tanya Ramey is an author at Pfizer (United States) specializing in psychopharmacology, pharmacotherapy, and pharmacy.

Publications per year

2008–2015

7

Publications

7

Effects of Varenicline on Smoking Cessation in Adults With Stably Treated Current or Past Major Depression

Robert M. Anthenelli, Chad D. Morris, Tanya Ramey et al. · Annals of Internal Medicine · 2013 · 132 citations · Full text

, , +6

Efficacy and Safety of Desvenlafaxine 50 mg/d in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder

Anita H. Clayton, Susan G. Kornstein, Boadie W. Dunlop et al. · The Journal of Clinical Psychiatry · 2013 · 89 citations

, , +12

Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study

Eduard Vieta, Tanya Ramey, David Keller et al. · Journal of Psychopharmacology · 2008 · 77 citations

, , +15

Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment

Karl Rickels, Thomas Shiovitz, Tanya Ramey et al. · International Clinical Psychopharmacology · 2012 · 67 citations

, , +17

Abrupt Discontinuation Compared With a 1-Week Taper Regimen in Depressed Outpatients Treated for 24 Weeks With Desvenlafaxine 50 mg/d

Arif Khan, Jeff Musgnung, Tanya Ramey et al. · Journal of Clinical Psychopharmacology · 2014 · 31 citations

, , +17

1–5 of 7